Clinical impacts of positive intraepithelial neoplasia at pancreatic transection margin in pancreatic cancer surgery
Pancreatology · 2024
DOI: 10.1016/j.pan.2024.02.005 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pancreatology, 2024. Verfasst von Satoshi Takada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kanazawa University, Japan. Electronic address: s.takada@med.kanazawa-u.ac.jp. Hauptthemen laut MEDLINE: Carcinoma in Situ, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND/OBJECTIVES: The outcomes of patients with intraepithelial neoplasia at the pancreatic transection margin after pancreatic cancer surgery remain unclear. We evaluated the clinical impact of pancreatic transection margin status. METHODS: This retrospective observational study included 171 patients who underwent surgery for pancreatic ductal adenocarcinoma between January 2008 and December 2019. Patients were classified into three groups: negative pancreatic transection margin (group N), positive low-grade (group L), and positive high-grade (group H) intraepithelial neoplasia. The clinicopathological findings and prognoses were analyzed for each group. RESULTS: There were 140, 14, and 9 patients in groups N, L, and H, respectively. The median age was significantly higher in group H (p = 0.035). There were no significant differences in male ratio, preoperative chemotherapy administration rate, pretreatment tumor markers, operative procedure, operative time, or blood loss. Overall survival and recurrence-free survival were not significantly different; however, the cumulative risk of recurrence in the remnant pancreas was significantly higher in group H (p = 0.018). CONCLUSIONS: Intraepithelial neoplasia at the pancreatic transection margin did not affect overall/recurrence-free survival. As patients with high-grade intraepithelial neoplasia at the pancreatic transection margin have an increased risk of recurrence in the remnant pancreas, careful postoperative follow-up is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kanazawa University, Japan. Electronic address: s.takada@med.kanazawa-u.ac.jp.
- Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kanazawa University, Japan.
- Department of Diagnostic Pathology, Kanazawa University Hospital, Japan.
- Innovative Clinical Research Center, Kanazawa University, Japan.
Zitieren
APA
Takada, S., Makino, I., Katano, K., Sugita, H., Tokoro, T., Gabata, R., Okazaki, M., Nakanuma, S., Ikeda, H., Toyama, T., & Yagi, S. (2024). Clinical impacts of positive intraepithelial neoplasia at pancreatic transection margin in pancreatic cancer surgery. Pancreatology. https://doi.org/10.1016/j.pan.2024.02.005
Vancouver
Takada S, Makino I, Katano K, Sugita H, Tokoro T, Gabata R, et al. Clinical impacts of positive intraepithelial neoplasia at pancreatic transection margin in pancreatic cancer surgery. Pancreatology. 2024. doi:10.1016/j.pan.2024.02.005
BibTeX
@article{Takada2024,
author = {Takada, Satoshi and Makino, Isamu and Katano, Kaoru and Sugita, Hiroaki and Tokoro, Tomokazu and Gabata, Ryosuke and Okazaki, Mitsuyoshi and Nakanuma, Shinichi and Ikeda, Hiroko and Toyama, Tadashi and Yagi, Shintaro},
title = {Clinical impacts of positive intraepithelial neoplasia at pancreatic transection margin in pancreatic cancer surgery},
journal = {Pancreatology},
year = {2024},
doi = {10.1016/j.pan.2024.02.005}
}
EUVIMED